Medicure Inc. (OTCMKTS:MCUJF) Short Interest Up ? in August

Medicure Inc. (OTCMKTS:MCUJF) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 5,532 shares, a growth of ? from the August 15th total of 0 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 26,278 shares, the short-interest ratio is currently 0.2 days.

Medicure Price Performance

MCUJF opened at $1.79 on Tuesday. The stock’s 50-day moving average price is $1.08 and its 200 day moving average price is $0.90. Medicure has a 12-month low of $0.67 and a 12-month high of $1.89. The firm has a market cap of $18.69 million, a price-to-earnings ratio of -3.51 and a beta of 1.15. The company has a current ratio of 0.97, a quick ratio of 0.64 and a debt-to-equity ratio of 0.02.

Medicure (OTCMKTS:MCUJF) last released its earnings results on Friday, August 14th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). The company had revenue of $5.36 million during the quarter, compared to analysts’ expectations of $2.45 million. Medicure had a negative net margin of 23.14% and a negative return on equity of 54.55%.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.